Our results from all-comers population genetic screening confirmed that rare pLOF variants in BRCA1, BRCA2, PALB2, ATM, and CHEK2 confer significant risk to breast cancer in the overall population.7 This evidence concerns the gene PALB2 and breast carcinoma.